Edition:
India

Irras AB (IRRAS.ST)

IRRAS.ST on Stockholm Stock Exchange

28.40SEK
18 Oct 2019
Change (% chg)

-0.10kr (-0.35%)
Prev Close
28.50kr
Open
28.60kr
Day's High
29.50kr
Day's Low
28.20kr
Volume
19,787
Avg. Vol
41,503
52-wk High
43.50kr
52-wk Low
21.40kr

Latest Key Developments (Source: Significant Developments)

IRRAS Q2 EBIT Loss Widens To SEK 40.7 Million
Thursday, 29 Aug 2019 

Aug 29 (Reuters) - Irras AB ::Q2 NET REVENUE TOTALED SEK 1.1 MILLION (0.1).Q2 EBIT LOSS SEK 40.7 MILLION VERSUS LOSS SEK 32.1 MILLION YEAR AGO.  Full Article

IRRAS Announces Issuance Of New Patent For Core IRRAflow Technology
Thursday, 1 Aug 2019 

Aug 1 (Reuters) - Irras AB ::IRRAS ANNOUNCES ISSUANCE OF NEW PATENT FOR CORE IRRAFLOW® TECHNOLOGY.PATENT IS PART OF A FAMILY OF PATENTS AND PATENT APPLICATIONS THAT PROTECT CORE FLUID MANAGEMENT PLATFORM IN IRRAFLOW FLUID MANAGEMENT SYSTEM.  Full Article

Irras Gets Regulatory Approval For Irraflow In Israel And Costa Rica
Tuesday, 25 Jun 2019 

June 25 (Reuters) - Irras AB ::RECEIVED REGULATORY APPROVAL FOR ITS FLAGSHIP PRODUCT, IRRAFLOW, FROM MINISTRIES OF HEALTH IN ISRAEL AND COSTA RICA.  Full Article

IRRAS Completes Directed Share Issue Of Around SEK 106 Mln
Thursday, 23 May 2019 

May 23 (Reuters) - Irras AB ::SAID ON WEDNESDAY THAT CO HAS SUCCESSFULLY COMPLETED A DIRECTED SHARE ISSUE.COMPANY WILL RECEIVE GROSS PROCEEDS OF AROUND SEK 106 MILLION.THE PROCEEDS FROM THE ISSUE WILL SUPPORT IRRAS’ ONGOING LAUNCH OF IRRAFLOW IN THE UNITED STATES AND GLOBALLY.AS A RESULT OF THE ISSUE, IRRAS IS CAPITALIZED UNTIL Q3/Q4 2020.  Full Article

Irras Buys Proprietary Assets
Tuesday, 7 May 2019 

May 7 (Reuters) - Irras AB ::IRRAS STRENGTHENS POSITION IN NEUROCRITICAL CARE BY ACQUIRING PROPRIETARY ASSETS, INCLUDING FOUR US FDA-CLEARED PRODUCTS.ASSETS COMPLEMENT IRRAFLOW AND SUPPORT POSITIONING AS A LEADING COMPANY IN SPACE.SALES OF ACQUIRED PRODUCTS WILL BE INITIATED IN US IN Q3.TOTAL PURCHASE PRICE FOR ASSETS WAS 700,000 USD..  Full Article

Irras Q1 Operating Loss Widens To SEK 39.1 Million
Tuesday, 7 May 2019 

May 7 (Reuters) - Irras AB ::(PUBL)INTERIM REPORT JANUARY-MARCH 2019.Q1 NET REVENUE TOTALED SEK 0.0 MILLION (5.9).Q1 OPERATING LOSS (EBIT) AMOUNTED TO SEK -39.1 MILLION (-21.1).  Full Article

Irras AB Receives An Updated ISO 134852016 Certificate
Wednesday, 9 May 2018 

May 9 (Reuters) - Irras AB ::RECEIVED AN UPDATED ISO 13485:2016 CERTIFICATE AND UPDATED CE MARKS FOR ITS CONTROL UNIT AND TUBE SET.ISO CERTIFICATE AND CE MARKS ARE VALID UNTIL 2021..  Full Article

Irras Oct-Dec EBIT Loss At SEK 23.7 Mln
Wednesday, 21 Feb 2018 

Feb 21 (Reuters) - IRRAS AB ::OCT-DEC REVENUE ACCOUNTED TO MSEK 0.7 (0.0).OCT-DEC OPERATING PROFIT (EBIT) WAS MSEK -23.7 (-10.1)..BOARD OF DIRECTORS PROPOSES NO DIVIDEND.OCT-DEC NET PROFIT AMOUNTED TO MSEK -23.2 (-10.4).  Full Article

IRRAS Announces Voluntary Recall On IRRAflow Device
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - IRRAS AB ::IRRAS ANNOUNCES VOLUNTARY RECALL ON ITS IRRAFLOW™ DEVICE DUE TO AN ISOLATED INCIDENT OF A BATTERY MANUFACTURING FAILURE.IRRAS BELIEVES THIS IS AN ISOLATED INCIDENT OF A MANUFACTURING FAILURE.RELEVANT REGULATORY BODIES WILL BE NOTIFIED OF VOLUNTARY RECALL.‍DOES NOT ANTICIPATE LONG-TERM IMPACT IN ADOPTION AND CLINICAL USE OF IRRAFLOW DEVICE DUE TO ISOLATED INCIDENT​.VOLUNTARY RECALL WILL AFFECT 2017 SALES OF IRRAFLOW™ ON TWO FRONTS.‍2020 OBJECTIVE OF SALES EXCEEDING 250 MSEK REMAINS INTACT​.  Full Article

BRIEF-IRRAS Completes Directed Share Issue Of Around SEK 106 Mln

* SAID ON WEDNESDAY THAT CO HAS SUCCESSFULLY COMPLETED A DIRECTED SHARE ISSUE